Skip to main content
. 2009 Aug 12;83(20):10494–10503. doi: 10.1128/JVI.00928-09

TABLE 1.

Classification and characterization of virus stocks of HIV-1 group M and group O isolates used in this study

Virus isolate Group Subtype Coreceptor usagea p24 CA level (ng/ml)b TCID50 (IU/ml)c Infectivity (IU/ng of p24 CA)d
NL4-3 M B X4 35,144 68,080 1.94
2005 M B X4 3,827 1,540 0.40
2044 M B X4 1,743 1,778 1.02
ELI M D X4 4,570 178 0.04
JR-FL M B R5 4,315 41,248 9.56
Ba-L M B R5 9,400 316,228 33.64
IN22 M C R5 1,448 2,610 1.80
RU570 M G R5 442 562 1.27
RW9 M A R5 440 1,000 2.27
D117 M B R5 2,870 1,778 0.62
2901 O X4 55 1,540 28.00
1639 O R5 56 562 10.04
2549 O R5 117 562 4.80
6778 O R5 405 178 0.44
8913 O R5 58 178 3.07
13127 O R5 193 3,162 16.38
13740 O R5 124 562 4.53
9435 O R5 500 ND ND
a

Coreceptor usage was determined as described in Materials and Methods, and representative data are shown in Fig. 1.

b

CA, capsid protein.

c

The infectious titer was determined on a pool of phytohemagglutinin/IL-2-activated PBMCs from six donors by end-point limiting dilution 5 days after inoculation as reported previously (32). ND, not determined; IU, infectious units.

d

The arithmetic mean ± standard error of the mean of relative infectivity (IU/ng of p24 CA) was 5.26 ± 3.27 for group M isolates and 9.6 ± 3.65 for group O isolates. ND, not determined; IU, infectious units.